Forsta AP Fonden Cuts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Forsta AP Fonden decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 31.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,800 shares of the biotechnology company's stock after selling 6,200 shares during the quarter. Forsta AP Fonden's holdings in Axon Enterprise were worth $4,061,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Blue Trust Inc. raised its position in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company's stock worth $27,000 after purchasing an additional 79 shares during the last quarter. ICA Group Wealth Management LLC bought a new position in Axon Enterprise during the 4th quarter worth $26,000. Trivant Custom Portfolio Group LLC bought a new position in Axon Enterprise during the 1st quarter worth $31,000. First PREMIER Bank bought a new position in Axon Enterprise during the 1st quarter worth $33,000. Finally, Blue Bell Private Wealth Management LLC bought a new position in shares of Axon Enterprise in the 1st quarter worth about $41,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Buying and Selling at Axon Enterprise

In other news, CFO Brittany Bagley sold 4,338 shares of the business's stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the transaction, the chief financial officer now owns 98,825 shares in the company, valued at approximately $37,449,733.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, President Joshua Isner sold 25,811 shares of the company's stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the transaction, the president now owns 228,166 shares in the company, valued at $82,103,253.44. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Brittany Bagley sold 4,338 shares of the company's stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the transaction, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. The disclosure for this sale can be found here. In the last quarter, insiders sold 316,981 shares of company stock worth $115,281,744. Insiders own 6.10% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on AXON shares. Jefferies Financial Group started coverage on Axon Enterprise in a research report on Wednesday, July 17th. They issued a "buy" rating and a $385.00 price objective for the company. Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a research report on Wednesday, August 7th. Bank of America started coverage on Axon Enterprise in a research report on Wednesday, July 17th. They issued a "buy" rating and a $380.00 price objective for the company. Northland Securities lifted their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an "outperform" rating in a research report on Thursday, August 8th. Finally, Robert W. Baird lifted their price objective on Axon Enterprise from $360.00 to $400.00 and gave the stock an "outperform" rating in a research report on Tuesday, September 10th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $365.38.

Axon Enterprise Stock Down 1.3 %

AXON stock traded down $4.90 during mid-day trading on Friday, reaching $379.61. 506,481 shares of the company traded hands, compared to its average volume of 454,324. The stock has a market cap of $28.69 billion, a price-to-earnings ratio of 111.00, a P/E/G ratio of 10.30 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a fifty-two week low of $189.12 and a fifty-two week high of $385.00. The firm's 50 day moving average price is $338.92 and its 200 day moving average price is $314.68.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The company's quarterly revenue was up 34.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.80 EPS. As a group, equities research analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.